PL366150A1 - Nowe formy krystaliczne i solwaty chlorowodorku ondansetronu oraz sposoby ich wytwarzania - Google Patents

Nowe formy krystaliczne i solwaty chlorowodorku ondansetronu oraz sposoby ich wytwarzania

Info

Publication number
PL366150A1
PL366150A1 PL01366150A PL36615001A PL366150A1 PL 366150 A1 PL366150 A1 PL 366150A1 PL 01366150 A PL01366150 A PL 01366150A PL 36615001 A PL36615001 A PL 36615001A PL 366150 A1 PL366150 A1 PL 366150A1
Authority
PL
Poland
Prior art keywords
processes
preparation
novel crystal
ondansetron hydrochloride
solvate forms
Prior art date
Application number
PL01366150A
Other languages
English (en)
Inventor
Ramy Lidor-Hadas
Judith Aronhime
Revital Lifshitz
Shlomit Weizel
Valerie Niddam
Asher Maymon
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL366150A1 publication Critical patent/PL366150A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
PL01366150A 2000-10-30 2001-10-30 Nowe formy krystaliczne i solwaty chlorowodorku ondansetronu oraz sposoby ich wytwarzania PL366150A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24428300P 2000-10-30 2000-10-30
US25381900P 2000-11-29 2000-11-29
US26553901P 2001-01-31 2001-01-31

Publications (1)

Publication Number Publication Date
PL366150A1 true PL366150A1 (pl) 2005-01-24

Family

ID=27399743

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366150A PL366150A1 (pl) 2000-10-30 2001-10-30 Nowe formy krystaliczne i solwaty chlorowodorku ondansetronu oraz sposoby ich wytwarzania

Country Status (20)

Country Link
US (1) US20020107275A1 (pl)
EP (1) EP1339707A2 (pl)
JP (1) JP2004525083A (pl)
KR (1) KR20030042038A (pl)
CN (1) CN1498216A (pl)
AU (1) AU2002230935A1 (pl)
CA (1) CA2426026A1 (pl)
CZ (1) CZ20031397A3 (pl)
DE (1) DE01991193T1 (pl)
ES (1) ES2204358T1 (pl)
HR (1) HRP20030432A2 (pl)
HU (1) HUP0401239A2 (pl)
IL (1) IL155644A0 (pl)
IS (1) IS6797A (pl)
MX (1) MXPA03003761A (pl)
NO (1) NO20031928L (pl)
PL (1) PL366150A1 (pl)
SK (1) SK6182003A3 (pl)
WO (1) WO2002036558A2 (pl)
YU (1) YU32003A (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK9892003A3 (en) * 2001-01-11 2004-05-04 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
DK1499623T3 (da) 2002-04-29 2007-10-08 Teva Gyogyszerg Ar Zartkoeruee Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
WO2006046253A1 (en) * 2004-10-26 2006-05-04 Ipca Laboratories Limited A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o
CN101410094B (zh) * 2006-01-27 2013-04-17 阿普塔利斯制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
KR20140088230A (ko) * 2006-01-27 2014-07-09 앱탈리스 파마테크, 인코포레이티드 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
US8133506B2 (en) 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
MY180626A (en) 2013-11-15 2020-12-03 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) * 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
DK1499623T3 (da) * 2002-04-29 2007-10-08 Teva Gyogyszerg Ar Zartkoeruee Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법

Also Published As

Publication number Publication date
CN1498216A (zh) 2004-05-19
SK6182003A3 (en) 2004-03-02
NO20031928D0 (no) 2003-04-29
KR20030042038A (ko) 2003-05-27
EP1339707A2 (en) 2003-09-03
US20020107275A1 (en) 2002-08-08
WO2002036558A3 (en) 2003-02-06
IL155644A0 (en) 2003-11-23
CA2426026A1 (en) 2002-05-10
YU32003A (sh) 2006-05-25
AU2002230935A1 (en) 2002-05-15
ES2204358T1 (es) 2004-05-01
JP2004525083A (ja) 2004-08-19
HUP0401239A2 (hu) 2004-12-28
CZ20031397A3 (cs) 2003-11-12
DE01991193T1 (de) 2004-07-08
NO20031928L (no) 2003-06-27
HRP20030432A2 (en) 2004-06-30
MXPA03003761A (es) 2003-07-28
IS6797A (is) 2003-04-29
WO2002036558A2 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
EP1383743A4 (en) DOUBLE INHIBITORS OF PDE 7 AND PDE 4
EP1193333A4 (en) METHOD FOR PRODUCING SILICON CRYSTALS AND SILICON CRYSTAL
HUP0500753A3 (en) Crystalline forms of valacyclovir hydrochloride
PT1600441E (pt) Forma cristalina de cloridrato de lercanidipina para utilização como agente anti-hipertensor
IL155644A0 (en) Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
AU2002337843A8 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
PL373845A1 (pl) Krystaliczne formy olanzapiny i sposoby ich otrzymywania
NO20042810L (no) Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav
AU2001291233A1 (en) Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
IL153916A0 (en) Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride obtained from said solvates
GB0115103D0 (en) Apparatus for and methods of preparing sperm
HK1055593A (en) Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
PL355426A1 (pl) Sposób wytwarzania amin drugorzędowych i trzeciorzędowych
HUP0001558A3 (en) Process for the preparation of pirlindole hydrochloride
AU2002213477A1 (en) Process for preparation of n-substituted 2-sulfanylimidazoles
EP1694242A4 (en) PHARMACEUTICAL PREPARATIONS OF CAMPTOTHECINS AND METHOD FOR OBTAINING THEM
HUP0302144A3 (en) Process of preparation of aliphatic amines
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
AU2003300814A8 (en) Polymorphic forms of ziprasidone and its hydrochloride
IL149807A0 (en) Process for the preparation of secondary and tertiary amines
AU2002348942A8 (en) Process for the preparation of tofisopam and new intermediates
HUP0203901A3 (en) Process for the preparation of secondary and tertiary amines
TWI319389B (en) Process for preparing succinonitrile and use of succinonitirile
PL332676A1 (en) Method of obtaining benzidamine hydrochloride
PL348216A1 (en) Method of obtaining n-(triarylmethyl)-1-amino-2-hydroxyalkanes